Diagnostic Approach for Crohn's Disease versus Ulcerative Colitis

Diagnostic Evaluation

The European Crohn's and Colitis Organisation recommends a complete ileocolonoscopy with multiple biopsies (at least two biopsies from five sites including the ileum and rectum) to differentiate Crohn's disease from ulcerative colitis, and to systematically complete with cross-sectional imaging (MRI or CT enterography) to evaluate the small intestine 1, 2, 3
A complete ileocolonoscopy is imperative to establish a differential diagnosis, even if an initial sigmoidoscopy suggests ulcerative colitis, according to the European Society of Gastrointestinal Endoscopy 2, 3
Systematically examine the terminal ileum and all colonic segments with a detailed description of lesions (type, location, depth, extent) 1
Take at least two biopsies from five different sites, including the ileum and rectum, even from areas of normal appearance, as recommended by the European Crohn's and Colitis Organisation 2, 3
Biopsies from unaffected areas are essential to document histologically the spared segments between inflammatory areas 1

Perform a systematic cross-sectional imaging (MRI or CT enterography) in all patients at diagnosis to evaluate the extent of the disease, the involvement of the small intestine, and to rule out complications, as recommended by the European Society of Gastrointestinal Endoscopy 1
Cross-sectional imaging is indispensable because about one-third of patients with Crohn's disease have small intestine involvement that is not detectable by colonoscopy 1

Systematically perform a basic biological assessment at diagnosis, including a complete blood count, CRP, albumin, liver function tests, iron status, renal function, and vitamin B12, as recommended by the European Crohn's and Colitis Organisation 1
Fecal calprotectin: sensitivity 93%, specificity 96% for diagnosing inflammatory bowel disease in adults; optimal threshold 100 μg/g 1
Lactoferrin as an alternative biomarker 1

In 5-15% of cases, endoscopic and histological evaluation does not allow differentiation between Crohn's disease and ulcerative colitis; capsule endoscopy of the small intestine can establish a definitive diagnosis by demonstrating small intestine lesions compatible with Crohn's disease in 17-70% of patients with unclassified inflammatory bowel disease, as reported by the European Crohn's and Colitis Organisation 2, 3, 4, 5
A negative capsule endoscopy does not definitively exclude a future diagnosis of Crohn's disease 4, 5

Ulcerative colitis typically begins in the rectum and extends proximally in a continuous fashion with gradually decreasing severity of inflammation 6
Crohn's disease shows a patchy, discontinuous distribution with skip lesions throughout the gastrointestinal tract 6
Rectal involvement is almost always present in untreated ulcerative colitis (>97% of cases), though therapy can sometimes alter this pattern 7, 6
Rectal sparing is a key distinguishing feature of Crohn's disease, occurring commonly, whereas it is rare in ulcerative colitis (described in only up to 3% of ulcerative colitis patients) 7, 6

Ulcerative colitis inflammation is limited to the mucosa and occasionally submucosa, while Crohn's disease inflammation is transmural (affecting all layers of the intestinal wall) 6
In ulcerative colitis, fibrosis is commonly restricted to mucosa or submucosa, whereas in Crohn's disease fibrosis can extend through all layers 6

Granulomas (non-cryptolytic) are absent in ulcerative colitis but present in Crohn's disease, serving as a key distinguishing feature 6
Crypt abscesses are more common in ulcerative colitis (41%) than in Crohn's disease (19%) 6
The inflammatory infiltrate in ulcerative colitis is diffuse without variations in intensity, while in Crohn's disease it varies in intensity within and between biopsies 6

Primary sclerosing cholangitis is more commonly associated with ulcerative colitis than with Crohn's disease 7
The presence of rectal sparing strongly suggests Crohn's disease rather than ulcerative colitis in a patient with inflammatory bowel disease 7
In 5-15% of inflammatory bowel disease patients, endoscopic and histological assessments cannot distinguish between Crohn's colitis and ulcerative colitis, leading to a classification of IBD-unclassified (IBD-U) 8, 6
Full ileocolonoscopy is recommended to delineate disease extent, severity of inflammation, and to distinguish between ulcerative colitis and Crohn's disease 8

CRP broadly correlates with clinical severity in ulcerative colitis (except proctitis) 9
Exclude infectious causes (e.g. infections) before finalizing diagnosis, as these can mimic inflammatory bowel disease 9

Perform a basic laboratory panel that includes a complete blood count, C‑reactive protein, albumin, liver function tests, iron studies, renal function, and vitamin B12 assessment to aid in the initial work‑up of suspected Crohn’s disease or ulcerative colitis. 10

Fecal calprotectin demonstrates a sensitivity of approximately 93 % and a specificity of about 96 % for detecting inflammatory bowel disease in adults, with an optimal diagnostic cutoff near 100 µg/g. 10
These non‑invasive biomarkers are useful for selecting patients who require endoscopic investigation, for gauging disease severity, and for identifying relapse. 10

Systematically rule out infectious etiologies before confirming an inflammatory bowel disease diagnosis, as infections can mimic IBD clinically and endoscopically. 10
Testing for Clostridioides difficile toxin is mandatory when an IBD flare is suspected, to avoid misdiagnosis and inappropriate therapy. 10
In cases of colitis recurrence, microbiological testing—including assays for C. difficile and cytomegalovirus—is recommended to detect treatable infections. 10

Anti‑neutrophil cytoplasmic antibodies (pANCA) are present in up to 65 % of patients with ulcerative colitis but in fewer than 10 % of those with Crohn’s disease; therefore, pANCA alone cannot reliably differentiate the two conditions. 10
Anti‑Saccharomyces cerevisiae antibodies (ASCA) are more frequently observed in Crohn’s disease, yet their diagnostic accuracy is insufficient for standalone use. 10